Pixium Plans 2014 Filing for Anti-Blindness Technology

Pixium Vision SA has enough test patients for its Iris retina-implant technology to start seeking European product-safety approval as early as this month in a bid to enter the growing market for alleviating blindness.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.